Key result
Antiarrhythmic drugs exert distinct electrophysiological effects on infarcted versus normal myocardium, requiring advanced testing methods.
Why the study?
Advances in cardiac electrophysiology and pharmacology since 1970 have improved understanding of antiarrhythmic drug efficacy and their effects on normal and diseased cardiac tissues.
Answers are grounded in this paper and cite their sources.
Advances in antiarrhythmic understanding may guide therapy selection; leaves open need for contemporary outcome trials.
This review of the disposition and e1ectrophysiological effects of antiarrhythmic drugs emphasizes literature published since 1970.2 We have restricted ourselves to a consideration of those drugs most widely used in the treatment of clinical arrhyth mias. Several important advances in cardiac electrophysiology and pharmacology have been made since the last review (1) which has furthered our understanding of the efficacy of these drugs. Progress continues to be made in our understanding of how the cardiac action potential is generated and propagated in the mammalian heart. Advances have been made both at the basic and clinical level in our under standing of the origin of cardiac arrhythmias. It is impossible to include a discussion of the ionic basis of the cardiac action potential and the electrophysiological basis for disturbances in cardiac rhythm in a review of limited length. The reader is referred to several recent reviews and monographs for these basic discussions (2-5). An area of active investigation has been the elucidation of the e1ectrophysiological properties of cells from diseased human hearts and canine hearts subjected to myocardial infarction. The electrophysiological effects of antiarrhythmic drugs on cells surviving infarction have only begun to be investigated, but already it is becoming evident that drug effects on normal tissue may be quite different from drug effects on diseased tissues. In vivo recording and stimulating techniques have been perfected which has allowed assessment of the electrophysiological effects of these drugs in man. Considerable progress has been achieved in analytical and computa tional methodology allowing some conclusions to be made about the relationship between time course of drug in the ·body and the time course of pharmacologic effect.
No takes yet. Share an insight, caveat, or question.
Sasyniuk et al. (1975) conducted a review in Clinical arrhythmias. Antiarrhythmic drugs was evaluated. Antiarrhythmic drugs exhibit distinct electrophysiological effects on normal versus infarcted cardiac tissues, necessitating advanced pharmacokinetic and in vivo assessment methodologies.
Synapse has enriched 10 related papers. Consider them for comparative context: